Instituto Americas
Rio de Janeiro 22793-334
1 studies enrolling now · 4 studies all time
What they study most
Breast Cancer, Follicular Lymphoma (FL), Locally Advanced or Unresectable Metastatic Breast Cancer, Metastatic Colorectal Cancer, Stage IV Breast Cancer
Studies at this site
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma — Recruiting now
- DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] — Running, not enrolling
- Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
- A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer — Running, not enrolling